Hosted by the Federation of European Neuroscience Societies (FENS)
Blood-borne biomarkers are an attractive, accessible tool to help us to understand the biological underpinnings of brain function in health and disease, given the limitations of non-invasive techniques such as brain imaging and our inability, outside of neurosurgery, to biopsy living human brain tissue.
In this webinar, we will discuss the challenges presented by the blood brain barrier to CNS biomarker discovery and use, the potential of extracellular vesicles as novel markers of brain function and dysfunction, and the clinical relevance of established and novel blood biomarkers of neuropsychiatric disorders and brain injury. We will also explore the limitations of the use of blood-borne CNS biomarkers both in the laboratory and the clinic and provide insights into the future development of novel biomarkers of brain health and disease.
Speakers:
- Áine Kelly (IE), Trinity College School of Medicine – Moderator
- Sabine Bahn (UK), Cambridge Centre for Neuropsychiatric Research, Cambridge University
- Matthew Campbell (IE), Smurfit Institute of Genetics, Trinity College Dublin
- Kenneth W. Witwer (US), Johns Hopkins University School of Medicine in Baltimore
- Rebekah Mannix (US), Harvard Medical School